Envista Holdings Corporation (NVST)
Envista (NVST) Earnings Expected to Grow: Should You Buy?
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
NVST vs. ABT: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Should You Add NVST Stock to Your Portfolio Right Now?
Envista's global expansion, smart acquisitions, and strong balance sheet support growth but forex risks remain a drag.
All You Need to Know About Envista (NVST) Rating Upgrade to Buy
Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
NVST vs. ABT: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Understanding Envista (NVST) Reliance on International Revenue
Examine the evolution of Envista's (NVST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
NVST Stock Up on Q1 Earnings and Revenue Beat, Margins Crash
Envista delivers better-than-expected top and bottom-line results for the first quarter of 2025.
Envista Holdings Corporation (NVST) Q1 2025 Earnings Conference Call Transcript
Envista Holdings Corporation (NYSE:NVST ) Q1 2025 Earnings Conference Call May 1, 2025 5:00 PM ET Company Participants Jim Gustafson - VP, IR Paul Keel - President and CEO Eric Hammes - CFO Conference Call Participants Jon Block - Stifel Jason Bednar - Piper Sandler Elizabeth Anderson - Evercore ISI Jeff Johnson - Baird Allen Lutz - Bank of America Steven Valiquette - Mizuho Securities Brandon Vazquez - William Blair Erin Wright - Morgan Stanley Michael Cherny - Leerink Partners Operator Hello, my name is Madison and I will be your conference call facilitator this afternoon. At this time, I would like to welcome everyone to Envista Holdings Corporation's First Quarter 2025 Earnings Results Conference Call.
Compared to Estimates, Envista (NVST) Q1 Earnings: A Look at Key Metrics
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Envista (NVST) Beats Q1 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.26 per share a year ago.
Envista Holdings: A Mixed Picture
Today, we take a deeper look at Envista Holdings Corporation, a dental supply and equipment company. The stock appears to be trying to bottom after a recent decline and despite negative analyst firm opinion on the shares. The company has recently instituted a significant stock buyback program and from a historical perspective, the shares are cheap on a price to sales ratio basis.
